COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum
- 20 August 2020
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 41 (10), 1905-1907
- https://doi.org/10.3174/ajnr.a6713
Abstract
SUMMARY: There are very limited published data on the neurologic complications associated with coronavirus disease 2019 (COVID-19) in the pediatric population. Here we present the first 2 pediatric cases of presumed COVID-19 related cytotoxic lesions of the corpus callosum. Similar to reports in adults, these cases suggest that the COVID-19 infection in children may rarely mediate a hyperinflammatory response that can cause CNS pathology. As the pandemic continues further, the presentation of cytotoxic lesions of the corpus callosum should prompt radiologists to consider COVID-19, among other known causes.Keywords
This publication has 9 references indexed in Scilit:
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020
- Children with Covid-19 in Pediatric Emergency Departments in ItalyThe New England Journal of Medicine, 2020
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- COVID-19 and Kawasaki Disease: Novel Virus and Novel CaseHospital Pediatrics, 2020
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like DiseaseAutoimmunity Reviews, 2020
- Mild encephalitis with reversible splenial (MERS) lesion syndrome due to influenza B virusPractical Neurology, 2018
- Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and ManifestationsRadioGraphics, 2017
- Reversible splenial lesion syndrome in children: Retrospective study and summary of case seriesBrain & Development, 2016
- Two newly proposed infectious encephalitis/encephalopathy syndromesBrain & Development, 2009